Analysts from Seeking Alpha have identified Pfizer as the most attractive stock within the Big Pharma sector. This assessment comes amid a landscape where pharmaceutical companies...
Wall Street’s major indices experienced mixed outcomes on Friday as investors continued to assess the implications of the ongoing U.S. government shutdown, now in its third...
The world’s largest pharmaceutical companies experienced a significant surge in stock performance last week, following a major deal between Pfizer and the U.S. government. On October...
Pfizer is nearing a significant acquisition, targeting a deal valued at approximately $7.3 billion to buy the weight-loss drug manufacturer Metsera. According to the Financial Times,...
Pfizer is reportedly nearing a significant acquisition, aiming for a takeover of weight-loss drug manufacturer Metsera in a deal valued at approximately $7.3 billion. According to...
URGENT UPDATE: Pfizer Inc. has just raised its profit forecast for 2025, signaling a critical shift in its financial strategy as the company faces declining sales...
